The authors of An additional paper documented the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [11].Youn et al. [fifty four] highlighted The dearth of consensus in dealing with CRAO through a national study in The usa. The research